A still, matte bone-colored surface with a deep teal structure resolving into view beneath it and one faint matcha edge, an abstract image of an inherited trait set in place below a calm surface.

The Long Game ·

Lp(a), the Number You Inherit

Lp(a), or lipoprotein(a), is a cholesterol particle you inherit rather than earn, set largely by one gene, held steady for life, and usually left off a standard lipid panel that a physician has to order on purpose.

A cholesterol panel is one of the most familiar rituals in medicine. Blood is drawn, a few days pass, and a result arrives with an LDL number and, more often than not, the steadying word normal. For most people, that is where the story ends, and it feels like good news.

But a standard panel was built to measure a short list of numbers, and one of the most stubborn risk factors in all of cardiology is usually not on it. This one does not respond to the salad or the morning run. It was largely set before you took your first breath, written into a single gene, and it tends to hold steady for the rest of your life.

Its name is lipoprotein(a), written Lp(a) and often said aloud as "L P little a." Most people have never heard of it, and most panels never report it. This is a calm look at what it is, why you essentially inherited it, and why it can be worth learning your number one time.

A particle with an extra piece

Cholesterol does not move through the blood on its own. Because it is a fat, it travels wrapped inside particles called lipoproteins, each a small sphere of cargo bound in protein. LDL, the particle most people have heard named, is one of them.

Lp(a) is a close relative with one important difference. It is essentially an LDL-like particle carrying cholesterol, but with an extra protein, apolipoprotein(a), fastened to it. That single addition changes how it behaves. Apolipoprotein(a) structurally resembles a clot-related protein and carries inflammatory molecules called oxidized phospholipids, so a single Lp(a) particle can nudge plaque, inflammation, and clotting at the same time. Researchers describe it as independently atherogenic, meaning it adds to cardiovascular risk on its own, separate from your ordinary cholesterol.

Lipoprotein(a), or Lp(a), is a cholesterol-carrying particle much like LDL but with an extra protein, apolipoprotein(a), bonded to it. That added protein makes Lp(a) independently atherogenic, and because the level is set almost entirely by the LPA gene, it is inherited and stays largely fixed across adult life.

Written into the gene, not the routine

Here is the fact that sets Lp(a) apart from almost every other number on a lab report. Your level is largely inherited. Research consistently attributes something on the order of eighty to ninety percent or more of a person's Lp(a) level to genetics, chiefly a single gene called LPA. You receive your version from your parents, one copy from each, and the level it produces tends to be established early and to hold remarkably steady across adult life.

That stability cuts in an unfamiliar direction. The habits that move most of your other markers, a better diet, more exercise, losing weight, do not meaningfully lower Lp(a). Even standard statins, the workhorse of cholesterol care, do not lower it, and some evidence suggests they may nudge it slightly upward. This is not a number you can discipline your way out of. It sits closer to eye color than to body weight: a trait you were dealt, not a habit you built. It is also common, which is the next surprise.

Stable strata in bone and deep teal, layered and set in place, a pattern passed down rather than chosen.
Stable strata in bone and deep teal, layered and set in place, a pattern passed down rather than chosen.

Not the same as the cholesterol you know

It is easy to fold Lp(a) into the general idea of cholesterol, but it answers a different question. A standard lipid panel reports LDL cholesterol, which measures the amount of cholesterol riding inside your LDL particles, a useful number that for many people moves with diet, exercise, and medication. Lp(a) is different in kind. Where apoB counts all of your plaque-forming particles and can be modified, Lp(a) is one specific, inherited particle you cannot diet away. It carries cholesterol like its LDL cousin, but the level is set by your genes rather than your habits, so it stays largely fixed while other lipid numbers rise and fall. Put simply, most of a lipid panel describes risk you can change, while Lp(a) describes a baseline you were handed at birth. Knowing which number is which is what tells you, and a physician, where your effort can actually make a difference.

The panel that reads normal

This is where Lp(a) earns its reputation as a quiet risk. A standard lipid panel does not include it. Unless a physician specifically orders an Lp(a) test, the level is simply not measured and not reported, so it never appears on the page. A person can carry an excellent LDL number, a clean-looking panel, and years of reassurance, while an elevated Lp(a) sits underneath, entirely unaddressed because no one looked for it.

That is the heart of it: a panel can read normal while an inherited risk sits quietly beneath it, uncounted. The reassurance is genuine for the numbers that were measured, and misleading only about the one that was not. This is less a reason for alarm than a reason for awareness. Elevated Lp(a) is common and best understood as one manageable part of your total risk picture, not a verdict. But you cannot factor in a number you have never seen, which is why the first step is simply knowing it exists and asking whether it belongs on your next panel.

A calm, even surface lies untroubled while a single region of deeper tone rests just beneath it, unseen from above.
A calm, even surface lies untroubled while a single region of deeper tone rests just beneath it, unseen from above.

What the evidence connects it to

The reason any of this matters is what large studies keep finding. Across big population cohorts and genetic analyses, elevated Lp(a) is associated with a higher risk of atherosclerotic cardiovascular disease, the plaque-driven process behind most heart attacks, and with calcific aortic valve stenosis, a stiffening of a heart valve. Because the evidence includes genetic studies, in which people inherit higher or lower Lp(a) essentially at random, researchers regard the link as causal at the population level rather than a coincidence.

The relationship reads as a gradient, not a cliff: broadly, the higher the level, the higher the associated risk, and it climbs steadily rather than switching on at one line. To put rough numbers on it, analyses suggest that each increment of about 50 nmol/L in Lp(a) is associated with something like a ten percent rise in cardiovascular risk. These are population-level associations, not a personal prophecy. An elevated number raises the odds; it does not schedule an event, and it says nothing certain about any one person.

The number you learn once

So what does a person do with a number they cannot diet away? Less than it might seem, and also more. Because Lp(a) is so stable, major guideline bodies now suggest it is reasonable to measure it about once in a lifetime for most adults, a single data point that rarely needs repeating outside specific circumstances. Whether and when to check it is a conversation worth having with your physician, not a step to take on your own.

If the number comes back elevated, the response is focus rather than fear. As of this writing there is no widely approved medicine designed specifically to lower Lp(a), though several targeted therapies are in late-stage clinical trials. The productive work, guided by a physician, is on the risk you can move: LDL and overall particle burden, blood pressure, blood sugar, and the ordinary habits that lower cardiovascular risk across the board. An inherited number simply raises the value of managing everything else well.

That is the lens we bring at the practice: reading the whole pattern, including the inherited factors a routine panel skips, alongside a physician rather than in place of one. Lp(a) is not a number to fear. It is one you were handed, worth understanding once, so that the effort you spend lands where it can actually change the odds.

Common questions

What is Lp(a)?

Lipoprotein(a), or Lp(a), is a cholesterol-carrying particle similar to LDL but with an additional protein, apolipoprotein(a), attached to it. That extra protein makes Lp(a) independently atherogenic, meaning it can contribute to plaque, inflammation, and clotting on its own. The level is set almost entirely by genetics and tends to stay stable throughout adult life.

Is Lp(a) the same as LDL cholesterol?

No. LDL cholesterol measures the amount of cholesterol carried inside LDL particles and can often be changed with diet, exercise, and medication. Lp(a) is a distinct, inherited particle whose level is set largely by a single gene called LPA. They carry different information: LDL reflects risk you can usually modify, while Lp(a) reflects an inherited baseline that stays largely fixed.

Can you lower Lp(a) with diet or statins?

Because Lp(a) is largely determined by genetics, diet, exercise, and weight loss do not meaningfully lower it, and standard statins do not lower it either. As of this writing, there is no widely approved medicine designed specifically to lower Lp(a), although several targeted therapies are in late-stage clinical trials. When Lp(a) is elevated, the usual focus, guided by a physician, is on lowering overall cardiovascular risk through the factors that can be changed.

How often should Lp(a) be tested?

Because Lp(a) levels are inherited and stay stable over time, major guideline bodies suggest that measuring it about once in an adult's lifetime is generally enough for most people, with repeat testing reserved for specific situations. Whether and when to test Lp(a) is a decision to make with a physician as part of an overall cardiovascular risk assessment.

What is a normal Lp(a) level?

Thresholds vary by guideline and by the units used, and risk rises along a continuum rather than at a single cutoff. As a general reference, many organizations consider a level below 30 mg/dL (about 75 nmol/L) to be low risk and a level at or above 50 mg/dL (about 125 nmol/L) to be elevated, with the range in between viewed as intermediate. These are population reference points, not a personal cutoff, so interpreting your own result is a conversation to have with a physician.

Keep reading

More from The Journal

A calm bone field where a soft dawn luminance rises through matcha green into deep teal, an abstract image of morning light arriving over an unseen horizon.

Morning Light, and the Clock It Sets

Step outside in the morning and something invisible happens. The light reaches a set of cells that have nothing to do with seeing, and they set the clock the rest of the body runs on. A calm look at light as the body's master timing signal, and how the modern indoor day quietly turns it around.

Read
A calm bone field crossed by a single slow gradient rising in soft matcha and settling into deep teal, an abstract image of a daily rhythm the body quietly keeps.

Meal Timing, the Clock Your Metabolism Keeps

You can eat the same meal at 8 a.m. or 8 p.m., and the body reads it differently. A calm look at circadian metabolism, what time-restricted eating can and cannot do, and why the honest answer is earlier and consistent.

Read
A calm bone-colored field warmed by a soft, low-angle diffuse glow that gathers into a quiet matcha-into-deep-teal gradient, an abstract image of light becoming something the body quietly holds.

Vitamin D, the Hormone You Call a Vitamin

The number on your panel behaves less like a vitamin and more like a hormone your skin makes from light. A calm look at what 25-hydroxyvitamin D measures, why experts keep moving the line, and how to read your level without chasing it.

Read